Estimating ethnic differences in self-reported new use of antidepressant medications: Results from the Multi-Ethnic Study of Atherosclerosis

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 7, 2009, Pages 545-553

  Delaney, Joseph A C ^a   Oddson, Bruce E ^b   McClelland, Robyn L ^a   Psaty, Bruce M ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LAURENTIAN UNIVERSITY   (Canada)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Antidepressants; Drug utilization; Ethnicity; Inverse probability of censoring weighting; Multi Ethnic Study of Atherosclerosis; Non random loss to follow up

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; TRAZADONE; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CAUCASIAN; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; DEPRESSION; DRUG USE; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; INVERSE PROBABILITY OF CENSORING WEIGHTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; SOCIAL STATUS; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ATHEROSCLEROSIS; COHORT STUDIES; DEPRESSIVE DISORDER; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES;

EID: 69049083645     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1751     Document Type: Article

References (32)

1. Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among US adults. Pharmacoepidemiol Drug Saf 2007; 16(5): 560-570.
2. Han E, Liu GG. Racial disparities in prescription drug use for mental illness among population in US. J Ment Health Policy Econ 2005; 8(3): 131-143.
3. Ufer M, Meyer SA, Junge O, et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007; 16(10): 1153-1160.
4. Wei L, Chen R, MacDonald TM. Channelling of SSRIs and SNRIs use in the Tayside population, Scotland. Pharmacoepidemiol Drug Saf 2007; 16(8): 859-866.
5. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156(9): 871-881.
6. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 1992; 45(6): 683-692.
7. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
8. Golden SH, Lee HB, Schreiner PJ, et al. Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med 2007; 69(6): 529-536.
9. Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med 1997; 27(1): 231-235.
10. Spielberger CD, Johnson EH, Russell SF, Crane RJ, Jacobs GA, Worden TJ. The experience and expression of anger: construction and validation of an anger expression scale. In Chesney MA, Rosenman RH (eds). Anger and hostility in cardiovascular and behavioral medicine. Hemisphere: Washington DC, 1985.
11. Spielberger CD. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA, 1983.
12. Diez Roux AV, Ranjit N, Powell L, et al. Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. Ann Intern Med 2006; 144(11): 822-831.
13. Perreira KM, Deeb-Sossa N, Harris KM, Bollen K. What are we measuring? An evaluation of the CES-D across race/ethnicity and immigrant generation. Soc Forces 2005; 83(4): 1567-1602.
14. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
15. Breslow NE. Covariance analysis of censored survival data. Biometrics 1974; 30: 89-99.
16. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11(5): 561-570.
17. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000; 56: 779-788.
18. Lefebvre G, Delaney JA, Platt RW. Impact of mis-specification of the treatment model on estimates from a marginal structural model. Stat Med 2008; 27(18): 3629-3642.
19. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999; 8: 3-15.
20. Moodie EE, Delaney JA, Lefebvre G, Platt RW. Missing data in marginal structural models: a comparison of inverse probability weighting and multiple imputation. Int J Biostat 2008; 4(1): 13.
21. Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008; 179(2): 135-144.
22. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care 2003; 41(4): 479-489.
23. Miranda J, Duan N, Sherbourne C, et al. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. Health Serv Res 2003; 38(2): 613-630.
24. Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J Clin Psychiatry 2006; 67(6): 972-982.
25. Pomerantz JM, Finkelstein SN, Berndt ER, et al. Prescriber intent, off-label usage, and early discontinuation of antidepressants: a retrospective physician survey and data analysis. J Clin Psychiatry. 2004; 65(3): 395-404.
26. Golding JM, Lipton RI. Depressed mood and major depressive disorder in two ethnic groups. J Psychiat Res 1990; 24(1): 65-82.
27. de Boo GM, Kolk AM. Ethnic and gender differences in temperament, and the relationship between temperament and Depressive and Aggressive mood. Personality and Individual Differences 2007; 43(7): 756-1766.
28. Mills TL, Henretta JC. Racial, ethnic, and sociodemographic differences in the level of psychosocial distress among older Americans. Res Aging 2001; 23(2): 131-152.
29. Kanazawa A, White PM, Hampson SE. Ethnic variation in depressive symptoms in a community sample in Hawaii. Cultural Diversity and Ethnic Minority Psychology 2007; 13(1); 35-44.
30. Frances A, Manning D, Marin D, et al. Relationship of anxiety and depression. Psychopharmacology (Berl) 1992; 106 (Suppl): S82-S86.
31. Robbins PR, Tanck RH. Anger and depressed affect: interindividual and intraindividual perspectives. J Psychol 1997; 131: 489-500.
32. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74(4): 658-670.